Literature DB >> 3004972

Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level.

M Mackay, M Goman, N Bone, J E Hyde, J Scaife, U Certa, H Stunnenberg, H Bujard.   

Abstract

The gene for the precursor of Plasmodium falciparum merozoite surface antigens has been cloned. The entire sequence of the gene from a Thai isolate of the parasite is reported. It provides evidence for a signal peptide, a region containing short repeating peptides and an anchor sequence. In addition, the 5' end of a Papua New Guinea isolate has been sequenced. Comparison of these and other sequences defines, at the genetic level, a polymorphic region in the protein, and suggests that other parts of the protein are less susceptible to variation. Furthermore it appears that several signal peptides of P. falciparum exhibit extensive sequence homologies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004972      PMCID: PMC554737          DOI: 10.1002/j.1460-2075.1985.tb04154.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

2.  Evidence for a malarial parasite interaction site on the major transmembrane protein of the human erythrocyte.

Authors:  M J Friedman; M Fukuda; R A Laine
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

3.  Signal sequences. The limits of variation.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1985-07-05       Impact factor: 5.469

4.  The gene for an exported antigen of the malaria parasite Plasmodium falciparum cloned and expressed in Escherichia coli.

Authors:  I A Hope; M Mackay; J E Hyde; M Goman; J Scaife
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

5.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum.

Authors:  J S McBride; C I Newbold; R Anand
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

10.  Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoites.

Authors:  A Cheung; A R Shaw; J Leban; L H Perrin
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

View more
  25 in total

1.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.

Authors:  G S Hui; C Hashiro; C Nikaido; S E Case; A Hashimoto; H Gibson; P J Barr; S P Chang
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

4.  The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.

Authors:  J M Burns; T M Daly; A B Vaidya; C A Long
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Isolation and characterization of the 80,000 dalton Plasmodium falciparum merozoite surface antigen.

Authors:  W Strych; A Miettinen-Baumann; F Lottspeich; H G Heidrich
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

6.  Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates.

Authors:  R Ramasamy; D A Wijesundere; K Nagendran; M S Ramasamy
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

7.  Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

Authors:  A Cheung; J Leban; A R Shaw; B Merkli; J Stocker; C Chizzolini; C Sander; L H Perrin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Insights into the Performance of SD Bioline Malaria Ag P.f/Pan Rapid Diagnostic Test and Plasmodium falciparum Histidine-Rich Protein 2 Gene Variation in Madagascar.

Authors:  Nigani Willie; Rajeev K Mehlotra; Rosalind E Howes; Tovonahary A Rakotomanga; Stephanie Ramboarina; Arsène C Ratsimbasoa; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

9.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Conservation of antigen components from two recombinant hybrid proteins protective against malaria.

Authors:  B Knapp; U Nau; E Hundt
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.